DK146511B - PROCEDURE FOR REDUCING LIPID AND NUCLEIC ACID CONTENTS IN MICROBIAL CELL MASS - Google Patents
PROCEDURE FOR REDUCING LIPID AND NUCLEIC ACID CONTENTS IN MICROBIAL CELL MASS Download PDFInfo
- Publication number
- DK146511B DK146511B DK337677AA DK337677A DK146511B DK 146511 B DK146511 B DK 146511B DK 337677A A DK337677A A DK 337677AA DK 337677 A DK337677 A DK 337677A DK 146511 B DK146511 B DK 146511B
- Authority
- DK
- Denmark
- Prior art keywords
- cell mass
- methanol
- nucleic acid
- water
- solvent
- Prior art date
Links
- 150000002632 lipids Chemical class 0.000 title description 20
- 150000007523 nucleic acids Chemical class 0.000 title description 20
- 102000039446 nucleic acids Human genes 0.000 title description 20
- 108020004707 nucleic acids Proteins 0.000 title description 20
- 238000000034 method Methods 0.000 title description 15
- 230000000813 microbial effect Effects 0.000 title description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 72
- 210000004027 cell Anatomy 0.000 description 41
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 33
- 239000002904 solvent Substances 0.000 description 25
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 24
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 16
- 229910021529 ammonia Inorganic materials 0.000 description 13
- 239000000203 mixture Substances 0.000 description 11
- 239000000463 material Substances 0.000 description 10
- 238000000605 extraction Methods 0.000 description 9
- 239000000047 product Substances 0.000 description 8
- 239000000725 suspension Substances 0.000 description 8
- 239000000243 solution Substances 0.000 description 7
- 239000007858 starting material Substances 0.000 description 7
- 238000003756 stirring Methods 0.000 description 7
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 6
- 235000011114 ammonium hydroxide Nutrition 0.000 description 6
- 238000001914 filtration Methods 0.000 description 6
- 244000005700 microbiome Species 0.000 description 6
- 235000015097 nutrients Nutrition 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- 239000007791 liquid phase Substances 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 239000013049 sediment Substances 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 4
- 239000007789 gas Substances 0.000 description 4
- 230000009965 odorless effect Effects 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- 241000589341 Methylomonas clara Species 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- 230000001413 cellular effect Effects 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 239000003925 fat Substances 0.000 description 3
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 239000007790 solid phase Substances 0.000 description 3
- 210000005253 yeast cell Anatomy 0.000 description 3
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 241000589344 Methylomonas Species 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 229930182555 Penicillin Natural products 0.000 description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
- 241000235015 Yarrowia lipolytica Species 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- HXCHRJMJMALFHP-UHFFFAOYSA-N azanium;ethanol;hydroxide Chemical compound N.O.CCO HXCHRJMJMALFHP-UHFFFAOYSA-N 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- ZYBWTEQKHIADDQ-UHFFFAOYSA-N ethanol;methanol Chemical compound OC.CCO ZYBWTEQKHIADDQ-UHFFFAOYSA-N 0.000 description 2
- 239000012065 filter cake Substances 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 235000021588 free fatty acids Nutrition 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 150000002334 glycols Chemical group 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 229940049954 penicillin Drugs 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 229930000044 secondary metabolite Natural products 0.000 description 2
- 238000004062 sedimentation Methods 0.000 description 2
- 238000001694 spray drying Methods 0.000 description 2
- 238000005292 vacuum distillation Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 239000002028 Biomass Substances 0.000 description 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 108010058643 Fungal Proteins Proteins 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 241000228150 Penicillium chrysogenum Species 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- CBHOOMGKXCMKIR-UHFFFAOYSA-N azane;methanol Chemical compound N.OC CBHOOMGKXCMKIR-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 150000008280 chlorinated hydrocarbons Chemical class 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- -1 ethanol or methanol Chemical compound 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- DGEYTDCFMQMLTH-UHFFFAOYSA-N methanol;propan-2-ol Chemical compound OC.CC(C)O DGEYTDCFMQMLTH-UHFFFAOYSA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/08—Reducing the nucleic acid content
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Extraction Or Liquid Replacement (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Description
(19) DANMARK (W)(19) DENMARK (W)
§ „g FREMLÆGGELSESSKRIFT ,,,)146511 B§ "g PRESENTATION," 146511 B
DIREKTORATET FOR PATENT- 06 VAREMÆRKEVÆSENETDIRECTORATE OF THE PATENT 06 BRAND
(21) Patentansøgning nr.: 3376/77 (51) Irrt.CI.3: C12N 1/08 , „ . . C12 N 1/32 (22) Indlevenngsdag: 26 jul 1977 (41) Aim. tilgængelig: 28 jan 1978 (44) Fremlagt: 24 okt 1983 (86) International ansøgning nr.:- (30) Prioritet: 27 jul 1976 DE 2633666 (71) Ansøger: ‘HOECHST AKTIENGESELLSCHAFT; 6230 Frankfurt/Main 80, DE.(21) Patent Application No: 3376/77 (51) Irrt.CI.3: C12N 1/08, „. . C12 N 1/32 (22) Date of filing: 26 Jul 1977 (41) Aim. available: 28 Jan 1978 (44) Submitted: 24 Oct 1983 (86) International Application No :- (30) Priority: 27 Jul 1976 DE 2633666 (71) Applicant: 'HOECHST AKTIENGESELLSCHAFT; 6230 Frankfurt / Main 80, DE.
(72) Opfinder: Merten *Schlingmann; DE, Laslo *Vertesy; DE.(72) Inventor: Merten * Schlingmann; DE, Laslo * Vertesy; THE.
(74) Fuldmægtig: Ingeniørfirmaet Budde, Schou & Co_ (54) Fremgangsmåde til formindskelse af lipid- og nucleinsyreindholdet i mikrobiel cellemasse(74) Plenipotentiary: The engineering firm Budde, Schou & Co_ (54) Procedure for reducing the lipid and nucleic acid content of microbial cell mass
Den foreliggende opfindelse angår en fremgangsmåde til formindskelse af lipid- og nucleinsyreindholdet i mikrobiel cellemasse. Hver mikroorganismecelle indeholder carbonhydrater, proteiner, lipider og nucleinsyrer. Mikrobiel cellemasses anvendelig-__ hed som næringskilde i fodere påvirkes imidlertid negativt af ind-The present invention relates to a method for reducing the lipid and nucleic acid content of microbial cell mass. Each microorganism cell contains carbohydrates, proteins, lipids and nucleic acids. However, the usefulness of microbial cell mass as a food source in feed is adversely affected by the presence of
OQOQ
hold af nucleinsyrer og lipider.holdings of nucleic acids and lipids.
T· Et indhold af nucleinsyrer er betænkeligt, da det fører til L|) (O patologiske tilstande (gigt, stendannelser). Lipider begrænser la- hT · Nucleic acid content is questionable as it leads to L |) (O pathological conditions (arthritis, stone formation). Lipids limit la-
Jpl ger holdbar heden, fordi de bliver harske og ødelægger smagen.Jpl provides durability because they become rancid and destroy the taste.
jjjjjj Det er derfor den foreliggende opfindelses formål at sænke li- Ω pid- og nucleinsyreindholdet i mikrobiel cellemasse. Ved kendte 2 146511 fremgangsmåder enten opløses lipiderne fra cellevæg og membran ved hjælp af organiske opløsningsmidler eller hydrolyseres ved behandling med vandige alkalier.It is therefore an object of the present invention to lower the lipid and nucleic acid content of microbial cell mass. In known processes, the lipids from cell wall and membrane are either dissolved by organic solvents or hydrolyzed by treatment with aqueous alkalis.
En kendt fremgangsmåde til opløsning af lipider fra mikroorganismer arbejder med blandinger af methanol og chloroform. Fremgangsmåden er kostbar og kan føre til toksiske produkter. Lipidekstrak-tioner med alkohol/vand-blandinger, ifølge tyske fremlæggelsesskrifter nr. 2.405.593 eller 2.137.038, egner sig dårligt til bakterier og er i teknisk udførelse ligeledes kostbar.A known method for dissolving lipids from microorganisms works with mixtures of methanol and chloroform. The process is costly and can lead to toxic products. Lipid extractions with alcohol / water mixtures, according to German Patent Specification No. 2,405,593 or 2,137,038, are poorly suited for bacteria and are also costly in technical design.
Andre kendte fremgangsmåder med henblik på at gøre mikrobiel cellemasse fattige på nucleinsyrer og lipider benytter alkalisk oplukning ved forhøjede temperaturer. En ulempe herved er frigørelsen af de ved hydrolysen opståede frie fedtsyrer, der udskilles sammen med proteinet.Other known methods for lowering microbial cell mass on nucleic acids and lipids employ alkaline uptake at elevated temperatures. A disadvantage of this is the release of the free fatty acids resulting from the hydrolysis which are excreted together with the protein.
Desuden overgår en del af de i proteinet indeholdte essentielle aminosyrer, f.eks. lysin, til en form, der ikke kan udnyttes af organismen.In addition, some of the essential amino acids contained in the protein, e.g. lysine, in a form that cannot be utilized by the organism.
Man hår nu fundet en fremgangsmåde til formindskelse af lipid-og nucleinsyreindholdet i mikrobiel cellemasse, hvilken fremgangsmåde er ejendommelig ved, at man i et første trin behandler cellemassen ved en temperatur mellem -20°C og 60°C med en ekstraktionsblanding af ammoniak eller ammoniumhydroxid og et organisk opløsningsmiddel valgt blandt alkoholer med formlen ROH, hvor R er en alkylgruppe, og glycoler og deres monoethere med formlenA method has now been found for reducing the lipid and nucleic acid content of microbial cell mass, characterized in that in a first step the cell mass is treated at a temperature between -20 ° C and 60 ° C with an extraction mixture of ammonia or ammonium hydroxide. and an organic solvent selected from alcohols of formula ROH wherein R is an alkyl group and glycols and their monoethers of formula
H0-(CH9) -OR1 IH0- (CH9) -OR1 I
« XX«XX
hvor R er hydrogen, methyl eller ethyl, og n er 2 eller 3, idet det samlede vandindhold under oplukningen er 0-30 vægtprocent og ammoniakkoncentrationen er 1-10 vægtprocent beregnet på den anvendte mængde opløsningsmiddel, og at man i et andet trin efter fraskil-lelse af ekstraktionsblandingen behandler cellemassen med vand ved en pH-værdi på 5-8,5 jfr. krav 1, skiller den vandige fase fra og, eventuelt efter ekstraktion med et af ovennævnte opløsningsmidler, tørrer cellemassen.where R is hydrogen, methyl or ethyl and n is 2 or 3, the total water content during the uptake being 0-30% by weight and the ammonia concentration being 1-10% by weight based on the amount of solvent used, and in a second step after separation The extraction mixture treats the cell mass with water at a pH of 5-8.5 cf. Claim 1 separates the aqueous phase and, optionally after extraction with one of the above solvents, dries the cell mass.
Som mikrobiel cellemasse anvendes fortrinsvis mikroorganismer, der f.eks. er fremstillet ved dyrkning på alkohol eller n-paraffi- 3 146511 ner i nærværelse af et vandigt næringsmedium og en gas, der indeholder frit oxygen. Som mikroorganismer anvendes fortrinsvis bakterier, gærsvampe og svampe.As microbial cell mass, microorganisms which are e.g. are prepared by growing on alcohol or n-paraffins in the presence of an aqueous nutrient medium and a gas containing free oxygen. As microorganisms, bacteria, yeasts and fungi are preferably used.
Eksempler på sådanne mikroorganismer er bakterier, der udnytter methanol, af slægten Methylomonas, f.eks. Methylomonas Clara ATCC 31226, eller gærarter såsom Candida lipolytica ATCC 20.383, der kan fås ved dyrkning på n-paraffiner i nærværelse af et vandigt næringsmedium.Examples of such microorganisms are bacteria utilizing methanol of the genus Methylomonas, e.g. Methylomonas Clara ATCC 31226, or yeasts such as Candida lipolytica ATCC 20.383, which can be obtained by growing on n-paraffins in the presence of an aqueous nutrient medium.
Der kan ligeledes anvendes svampetørmycelier. Dette cellemateriale fås som biprodukt fra antibiotikaudvinding, f.eks. fra penicillinfermenteringer, efter at antibiotiket er ekstraheret.Also, fungal dry mycelia can be used. This cellular material is obtained as a by-product of antibiotic extraction, e.g. from penicillin fermentations after the antibiotic is extracted.
Som opløsningsmidler med ovenstående formler kommer alkoholer med førstnævnte formel såsom methanol, ethanol, n-propanol og isopropanol i betragtning. Foretrukket er methanol og ethanol, især methanol. Foruden de nævnte alkoholer egner sig glycoler og deres monoethere med sidstnævnte formel især glycol og monomethyl-glycol.As solvents of the above formulas, alcohols of the former formula such as methanol, ethanol, n-propanol and isopropanol are considered. Preferred are methanol and ethanol, especially methanol. In addition to said alcohols, glycols and their monoethers of the latter formula are particularly suitable for glycol and monomethyl glycol.
Der kan sættes ammoniak i gasform (NH^) eller som koncentreret vandig opløsning (NH^OH) til de nævnte opløsningsmidler. Valget bestemmes af celletørmaterialets vandindhold og af mængden af og vandindholdet i det anvendte opløsningsmiddel. NH^OH egner sig til cellemasser med ringe fugtighedsindhold (0-15%), NH^ derimod bedre til cellemasser med højere vandindhold (10-30%).Ammonia can be added in gaseous form (NH 2) or as concentrated aqueous solution (NH 2 OH) to said solvents. The choice is determined by the water content of the cell dry material and by the amount and water content of the solvent used. NH 2 OH is suitable for low moisture cell masses (0-15%), while NH 2 is better for higher water cell masses (10-30%).
Den mængde lipider, der fjernes ved ekstraktion med ammoniak og opløsningsmiddel, afhænger af det samlede vandindhold, der beregnes i vægtprocent på den anvendte mængde opløsningsmiddel, og af NH^-koncentrationen i vægtprocent beregnet på det anvendte opløsningsmiddel .The amount of lipids removed by ammonia and solvent extraction depends on the total water content, calculated as a percentage by weight of the amount of solvent used, and by the NH4 concentration, by weight, of the solvent used.
Særlig gode forsøgsresultater opnås med et vægtforhold mellem cellemasse og opløsningsmiddel på 1:3 til 1:6 med methanol og ehta-nol, og 1:8 til 1:12 med propanol, glycol og monoglycolethere. Ammoniakkoncentrationen beregnet på mængden af opløsningsmiddel er ifølge opfindelsen hensigtsmæssigt 2-8 vægtprocent, fortrinsvis 3-5 vægtprocent. Summen af de vandmængder, der stammer fra cellemasse, opløsningsmiddel og eventuelt den vandige ammoniak, beløber sig til 0-30 vægtprocent, fortrinsvis 0-20 og særlig foretrukket 4 1465 11 0-10 vægtprocent beregnet på den anvendte mængde opløsningsmiddel, jfr. krav 2.Particularly good test results are obtained with a weight ratio of cell mass to solvent of 1: 3 to 1: 6 with methanol and ethanol, and 1: 8 to 1:12 with propanol, glycol and monoglycol ethers. The ammonia concentration calculated on the amount of solvent according to the invention is conveniently 2-8% by weight, preferably 3-5% by weight. The sum of the amounts of water derived from cell mass, solvent and optionally the aqueous ammonia amounts to 0-30 wt.%, Preferably 0-20, and particularly preferably 4 1465 11 0-10 wt.% Based on the amount of solvent used, cf. claim 2.
Når der arbejdes i teknisk målestok, kan man efter fermentering give afkald på en tørring af cellerne til et ringe restindhold af vand på 4% eller mindre. Det er tilstrækkeligt, at cellemassen har en sådan celletørvægt, at det samlede vandindhold efter tilsætning af den nødvendige mængde opløsningsmiddel ligger inden for det optimale område; eventuelt kan man tilsætte opløsningsmidlet gasformig NH^.When working on a technical scale, after drying, the cells can be desiccated to a low residual water content of 4% or less. It is sufficient that the cell mass has such a cell dry weight that the total water content after the addition of the required amount of solvent is within the optimum range; optionally, the solvent can be added gaseous NH 2.
Opløsningen af fedtstoffer fra de mikrobielle cellemasser foregår på den måde, at cellematerialet suspenderes i et eller flere af de nævnte opløsningsmidler og der tilføres NH^ eller tilsættes NH^OH. Fortrinsvis Sker blandingen af suspensionen ved omrøring. Behandlingstemperaturerne ligger som nævnt i intervallet -20 til +60°C, idet et interval på 5-50 og især på 10-30°C er foretrukket. Behandlingens varighed er 5-120 minutter, fortrinsvis 25-35 minutter. Behandlingen sker i reglen ved normaltryk.The dissolution of fats from the microbial cell masses takes place by suspending the cell material in one or more of the aforementioned solvents and adding NH 2 or adding NH 2 OH. Preferably, the mixture of the suspension occurs by stirring. The treatment temperatures are, as mentioned, in the range of -20 to + 60 ° C, with a range of 5-50 and especially of 10-30 ° C being preferred. The duration of treatment is 5-120 minutes, preferably 25-35 minutes. The treatment is usually done at normal pressure.
Efter at behandlingen med opløsningsmiddel/ammoniak er afsluttet, fraskilles det opnåede cellemateriale (protein) ved en fremgangsmåde efter behag såsom centrifugering, filtrering og sedimentering fra opløsningsmidlet.After the solvent / ammonia treatment is completed, the cellular material (protein) obtained is separated by a process such as centrifugation, filtration and sedimentation from the solvent.
Filtrering er det foretrukne. Det opnåede faste cellemateriale kan for at fjerne lipiderne så fuldstændigt som muligt behandles endnu engang med et af de nævnte organiske opløsningsmidler.Filtration is preferred. The solid cell material obtained can, in order to remove the lipids as completely as possible, be treated again with one of said organic solvents.
Remanensen kan tørres til fjernelse af rester af opløsningsmiddel og ammoniak. Denne tørring foretages under formindsket tryk, fortrinsvis 80-150 torr, og ved forhøjet temperatur, fortrinsvis 40-50°C. Det således affedtede og tørrede produkt er lugtløst.The residue can be dried to remove solvent and ammonia residues. This drying is carried out under reduced pressure, preferably 80-150 torr, and at elevated temperature, preferably 40-50 ° C. The product thus degreased and dried is odorless.
Den ved ovenstående nævnte fremgangsmåde af det faste cellemateriale fraskilte flydende fase inderholder ammoniak og opløste lipider. Det anvendte opløsningsmiddel kan ved vakuumdestillation skilles fra fedtstofferne og anvendes igen.The liquid phase separated liquid phase material mentioned above contains ammonia and dissolved lipids. The solvent used can be separated from the fats by vacuum distillation and used again.
Derefter optages de affedtede og eventuelt tørrede cellemasser i vand. Det foretrukne vægtforhold mellem vandmængder og cellemasse er 1:1 til 1:30, især 1:5 til 1:15. Vandmængden skal i det mindste være afmålt således, at en omrøring af suspensionen er mulig.Then, the degreased and possibly dried cell masses are taken up in water. The preferred weight ratio of water volumes to cell mass is 1: 1 to 1:30, especially 1: 5 to 1:15. The amount of water must be at least metered so that a suspension of the suspension is possible.
5 146511 pH-værdien under vandbehandlingen skal ligge i området 5-8,5, fortrinsvis 6-7,5 og indstilles eventuelt til dette område. Dette er især nødvendigt, dersom der skal anvendes ikke eller ikke fuldstændig tørrede cellemasser fra første trin, der så også stadig indeholder restmængder af ammoniak, hvilket kan føre til en høj pH-værdi.The pH value during the water treatment should be in the range 5-8.5, preferably 6-7.5, and optionally adjusted to this range. This is especially necessary if non-fully dried cell masses from the first stage are to be used, which then also still contain residual ammonia, which can lead to a high pH.
Denne ekstraktion af nucleinsyrer, salte, polysaccharider og vandopløselig sekundærmetabolitter med vand foregår i reglen i et temperaturinterval på 30-95°C ved normaltryk. Fortrinsvis er temperaturerne 40-70°C, særlig foretrukket 50-60°C. Ekstraktionens varighed kan alt efter ekstraktionstemperatur og vandmængde være 5-120 minutter, der opnås gode resultater med en ekstraktionstid på 25-45 minutter. Til adskillelse af faste og flydende bestanddele centrifugeres suspensionen, fortrinsvis ved temperaturer på 10-30°C. Andre egnede adskillelsesmetoder er sedimentering og filtrering.This extraction of nucleic acids, salts, polysaccharides and water-soluble secondary metabolites with water usually takes place in a temperature range of 30-95 ° C at normal pressure. Preferably, the temperatures are 40-70 ° C, especially preferably 50-60 ° C. Depending on the extraction temperature and the amount of water, the duration of the extraction can be 5-120 minutes, which results in an extraction time of 25-45 minutes. To separate solid and liquid components, the suspension is centrifuged, preferably at temperatures of 10-30 ° C. Other suitable separation methods are sedimentation and filtration.
For lettere at kunne skille cellemassen fra sættes der formålstjenligt til vandet i andet trin indtil 20 vægtprocent, fortrinsvis 5-15 vægtprocent af en lavere alkohol såsom ethanol eller methanol, fortrinsvis methanol.In order to more easily separate the cell mass, it is conveniently added to the water in the second step up to 20% by weight, preferably 5-15% by weight of a lower alcohol such as ethanol or methanol, preferably methanol.
Den faste fase befries efter gængse metoder såsom fryse-, vakuumeller sprøjtetørring for væskerester. Produktet er i besiddelse af behagelige lugtegenskaber, en lysere farve end udgangsmaterialet og en særlig god vandbindingsevne. På grund af fjernelsen af lipider og nucleinsyrer egner det sig især til fremstilling af foderstoffer.The solid phase is freed by conventional methods such as freeze, vacuum or spray drying for liquid residues. The product has pleasant odor properties, a lighter color than the starting material and a particularly good water-bonding ability. Due to the removal of lipids and nucleic acids, it is particularly suitable for the preparation of feed.
Således er ved fremgangsmåden ifølge opfindelsen lipiderne fjernet indtil et restindhold i produktet på 0,5-3,5 vægtprocent og nucleinsyrerne indtil et restindhold på 0,5-4,5 vægtprocent.Thus, in the process of the invention, the lipids are removed to a residual content of the product of 0.5-3.5% by weight and the nucleic acids to a residual content of 0.5-4.5% by weight.
Ved fremgangsmåden ifølge opfindelsen undgås ulemperne ved de kendte fremgangsmåder såsom behandling med opløsningsmidler og alkalisk oplukning. Chlorerede carbonhydrider er ikke nødvendige. Fjernelsen med blandinger af ammoniak og opløsningsmiddel er, især for bakteriers vedkommende, betydelig mere fuldstændig end ved behandling af cellemassen med blandinger af opløsningsmiddel og vand. Ekstreme temperatur- og pH-intervaller, der begrænser produktets anvendelighed, undgås. Energiforbruget er mindre end ved de kendte alkaliske oplukningsmetoder. Proteinberigelsen sker uden forekomst af store mængder af neutraliseringssalte.In the process according to the invention, the disadvantages of the known methods such as treatment with solvents and alkaline absorption are avoided. Chlorinated hydrocarbons are not needed. The removal of mixtures of ammonia and solvent is, in particular for bacteria, considerably more complete than in treating the cell mass with mixtures of solvent and water. Extreme temperature and pH ranges that limit the utility of the product are avoided. The energy consumption is less than the known alkaline opening methods. Protein enrichment occurs without the presence of large amounts of neutralization salts.
146511 6146511 6
Den af det faste cellemateriale fraskilte vandige fase indeholder foruden andre vandopløselige bestanddele nucleinsyrer, der kan udvindes ved kendte fremgangsmåder, f.eks. udfældning i sure medier, ultrafiltrering, dialyse eller enzymbehandling.The aqueous phase separated from the solid cell material contains, in addition to other water-soluble constituents, nucleic acids which can be recovered by known methods, e.g. precipitation in acidic media, ultrafiltration, dialysis or enzyme treatment.
Fremgangsmåden ifølge opfindelsen vil i det følgende blive nærmere belyst ved hjælp af eksempler.The method according to the invention will now be described in more detail by way of example.
Eksempel 1Example 1
Methylomonas clara ATCC 31226 dyrkes i en næringsopløsning indeholdende methanol som eneste carbonkilde, ammoniak som eneste nitrogenkilde, phosphat, jern- og magnesiumsalte og andre gængse sporelementer under aerobe betingelser. Den således fremstillede bakteriecellemasse skilles fra opløsningen og underkastes sprøjtetørring.Methylomonas clara ATCC 31226 is grown in a nutrient solution containing methanol as the sole carbon source, ammonia as the sole nitrogen source, phosphate, iron and magnesium salts and other common trace elements under aerobic conditions. The bacterial cell mass thus produced is separated from the solution and subjected to spray drying.
100 g af denne cellemasse tilsættes 300 g methanol. Under omrøring af suspensionen ledes 10 g NH^-gas ind og opløses heri. Ved afkøling holdes temperaturen under tilførslen på 25-35°C. Blandingen af methanol, ammoniak og cellemasse omrøres i 30 minutter ved 20°C.100 g of this cell mass is added to 300 g of methanol. While stirring the suspension, 10 g of NH 2 gas is introduced and dissolved therein. On cooling, the temperature is maintained during the supply of 25-35 ° C. The mixture of methanol, ammonia and cell mass is stirred for 30 minutes at 20 ° C.
For at adskille den faste og den flydende fase filtreres der, og den faste remanens vaskes med 300 ml methanol. Efter gentagen filtrering forenes begge filtrater. Denne brune opløsning indeholder lipiderne fra den anvendte begyndelsessubstans. Methanol og ammoniak fjernes ved vakuumdestillation (100 torr, 40°C). Remanensen, der udgør 9,5 vægtprocent af det anvendte cellemateriale, er en mørkebrun, ildelugtende pasta, der består af frie fedtsyrer, glycerider, phospholipider og sekundærmetabolitter.To separate the solid and liquid phase, filter and wash the solid residue with 300 ml of methanol. After repeated filtration, both filtrates are combined. This brown solution contains the lipids from the starting substance used. Methanol and ammonia are removed by vacuum distillation (100 torr, 40 ° C). The residue, which constitutes 9.5% by weight of the cellular material used, is a dark brown, smelly paste consisting of free fatty acids, glycerides, phospholipids and secondary metabolites.
Den ved filtrering opnåede faste remanens af den ekstraherede cellemasse tørres i vakuum (100 torr) ved 40°C i 5 timer. Der fås herved 90 g affedtet cellemasse, der er lugtløs og har en lysere farve end udgangsmaterialet.The solid residue obtained by filtration of the extracted cell mass is dried in vacuo (100 torr) at 40 ° C for 5 hours. Thereby 90 g of degreased cell mass is obtained which is odorless and has a lighter color than the starting material.
For at formindske indholdet af nucleinsyre suspenderes denne cellemasse i 900 ml vand. pH-værdien af den ved omrøring homogeniserede suspension er 6,9.To decrease the nucleic acid content, this cell mass is suspended in 900 ml of water. The pH of the stirred homogenized suspension is 6.9.
Efter at temperaturen er forhøjet til 55°C omrøres endnu i 20 minutter, afkøles til 30°C og der adskilles i fast og flydende fase ved centrifugering. Det fremkomne sediment blandes igen med 900 ml 7 U6511 vand og omrøres i 10 minutter ved 20°C. Derefter centrifugeres igen, og sedimentet tørres under formindsket tryk.After the temperature is raised to 55 ° C, stir for another 20 minutes, cool to 30 ° C and separate in solid and liquid phase by centrifugation. The resulting sediment is again mixed with 900 ml of 7 U6511 water and stirred for 10 minutes at 20 ° C. Then centrifuge again and the sediment is dried under reduced pressure.
Udbyttet vejer 65 g. Indholdet af nucleinsyre er fra oprindelig 11,2% faldet til 1,5%. Produktet er lugtløst i tør tilstand, fugtet med vand har det en behagelig lugt.The yield weighs 65 g. The nucleic acid content has dropped from 11.2% to 1.5%. The product is odorless in dry condition, moistened with water it has a pleasant smell.
Resultaterne af dette og de næste eksempler er anført i de efterfølgende tabeller la og Ib.The results of this and the following examples are set forth in the following Tables 1a and 1b.
Eksempel 2Example 2
Som udgangsmateriale anvendes samme bakteriecellemasse som i eksempel 1. Den underkastes samme behandlingstrin og betingelser, dog anvendes der i stedet for gasformig NHg 30 ml koncentreret 33%'s NH^OH som reagens.As the starting material, the same bacterial cell mass is used as in Example 1. It is subjected to the same treatment steps and conditions, however, instead of gaseous NHg 30 ml of concentrated 33% NH 2 OH is used as reagent.
Eksempel 3Example 3
Man går frem som beskrevet i eksempel 2, dog anvendes 60 ml koncentreret 33%'s NH^OH.Proceed as described in Example 2, however, 60 ml of concentrated 33% NH 2 OH are used.
Eksempel 4Example 4
Man går frem som beskrevet i eksempel 2, men anvender i stedet for methanol ethanol som opløsningsmiddel.Proceed as described in Example 2 but use methanol ethanol as a solvent instead.
Eksempel 5Example 5
Man går frem som beskrevet i eksempel 3, men anvender i stedet for methanol glykolmonomethylether som opløsningsmiddel.Proceed as described in Example 3, but instead use methanol glycol monomethyl ether as the solvent.
Eksempel 6Example 6
Man går frem som i eksempel 2, men anvender i stedet for methanol i-propanol som opløsningsmiddel.Proceed as in Example 2, but instead use methanol i-propanol as the solvent.
Eksempel 7Example 7
Som udgangsmateriale anvendes en cellemasse af Methylomonas clara som beskrevet i eksempel 1. 100 g af det sprøjtetørrede pro dukt oplukkes som beskrevet i eksempel 1 og affedtes (15 g NHg). Men der foretages ingen fuldstændig tørring af remanensen. Den omhyggeligt 8 148511 drænede filterkage med et faststofindhold på 85% suspenderes i 900 ml vand. pH-værdien indstilles på 8,9 betinget af den i den fugtige biomasse tilbageblevne ammoniak.As a starting material, a cell mass of Methylomonas clara is used as described in Example 1. 100 g of the spray-dried product is dissolved as described in Example 1 and degreased (15 g NHg). However, no complete drying of the residue is performed. The carefully drained filter cake with a solids content of 85% is suspended in 900 ml of water. The pH is adjusted to 8.9, depending on the ammonia remaining in the moist biomass.
Suspensionens temperatur forhøjes under omrøring til 65°C og efter 5 minutters forløb indstilles pH-værdien ved tilsætning af HC1 til 7,2. Herefter omrøres der i yderligere 15 minutter ved 65°C, derefter afkøles der til 40°C og centrifugeres. Det opnåede sediment tør res.The temperature of the suspension is raised with stirring to 65 ° C and after 5 minutes the pH is adjusted by adding HCl to 7.2. Then stir for an additional 15 minutes at 65 ° C, then cool to 40 ° C and centrifuge. The resulting sediment is dried.
Eksempel 8Example 8
En carbonhydrid-forbrugende stamme af gærarten Candida lipolytica ATCC 20.383 dyrkes på n-paraffiner i nærværelse af et vandigt næringsmedium og en oxygenholdig gas. Gærcellemassen skilles fra næringsopløsningen og tørres.A hydrocarbon-consuming strain of the yeast species Candida lipolytica ATCC 20,383 is grown on n-paraffins in the presence of an aqueous nutrient medium and an oxygen-containing gas. The yeast cell mass is separated from the nutrient solution and dried.
100 g af den tørre gærcellemasse suspenderes ved stuetemperatur under normaltryk i 300 g methanol, og denne blanding tilføres i løbet af 15 minutter 10 g NH^-gas. Herved holdes suspensionens temperatur ved afkøling på 15°C. Efter at gassen er tilført, omrøres der endnu i 20 minutter ved 22°C og derefter filtreres over en sugefritte. Filterkagen blandes engang med 300 ml methanol på fritten og suges derefter tør. De to filtrater forenes. Opløsningen er gul og indeholder lipiderne fra det anvendte cellemateriale. Methanol og NH^ fjernes ved formindsket tryk (14 torr).100 g of the dry yeast cell mass is suspended at room temperature under normal pressure in 300 g of methanol and this mixture is fed 10 g of NH This keeps the temperature of the suspension cooled to 15 ° C. After the gas is fed, stir for another 20 minutes at 22 ° C and then filtered over a suction fryer. Once filtered, mix the filter cake with 300 ml of methanol on the frit and then suck it dry. The two filtrates are combined. The solution is yellow and contains the lipids from the cell material used. Methanol and NH 2 are removed at reduced pressure (14 torr).
Den efter den anden filtrering tilbageblevne remanens, der består af ødelagte og affedtede mikroorganismeceller,tørres i et vakuumtørre-skab ved 40°C (100 torr) i 5 timer. Det herved fremkomne produkt har en lysere farve end den i begyndelsen anvendte gærcellemasse og er lugtløs.The residue remaining after the second filtration, consisting of broken and degreased microorganism cells, is dried in a vacuum dryer at 40 ° C (100 torr) for 5 hours. The resulting product has a lighter color than the yeast cell mass used initially and is odorless.
Til formindskelse af nucleinsyreindholdet fra oprindelig 7,5 vægtprocent beregnet på udgangsmaterialet suspenderes 100 g af den affedtede og tørrede gær i en opløsning af 1 liter destilleret vand og 100 ml methanol. Under omrøring bringes blandingens temperatur ved en pH-værdi på 6,8, der indstilles, i 15 minutter op på 50°C og adskilles ved centrifugering i et sediment, der indeholder gærproteinet, og en flydende fase, der indeholder opløseliggjort nucleinsyre. Sedimentet underkastes efter endnu engang vask ved stuetemperatur frysetørring.To reduce the nucleic acid content from the original 7.5% by weight based on the starting material, 100 g of the degreased and dried yeast is suspended in a solution of 1 liter of distilled water and 100 ml of methanol. With stirring, the temperature of the mixture is brought to a temperature of 6.8 which is adjusted to 15 ° C for 15 minutes and separated by centrifugation in a sediment containing the yeast protein and a liquid phase containing soluble nucleic acid. The sediment is subjected to washing again at room temperature freeze-drying.
Nucleinsyreindholdet i det tørrede materiale er faldet fra oprindelig 7,5 til 0,4 vægtprocent.The nucleic acid content of the dried material has dropped from originally 7.5 to 0.4% by weight.
9 1465119 146511
Eksempel 9Example 9
Man går frem som beskrevet i eksempel 8, men anvender i stedet for methanol ethanol og i stedet for 10 g gasformig NH^ 60 ml 33%'s nh4oh.Proceed as described in Example 8 but use instead of methanol ethanol and instead of 10 g of gaseous NH4 60 ml of 33% nh4oh.
Eksempel 10Example 10
Penicillium chrysogenum ATCC 10.238 dyrkes i en næringsopløsning indeholdende lactose, majsstivelse, flydende,, phosphat, carbonat og magnesiumsulfat aerobt på gængs måde. Efter fraskillelse af det producerede penicillin bliver myceliet tilbage, der tørret fungerer som udgangsmateriale.Penicillium chrysogenum ATCC 10.238 is grown in a nutrient solution containing lactose, corn starch, liquid, phosphate, carbonate and magnesium sulfate aerobically in conventional manner. After separation of the produced penicillin, the dried mycelium remains, which acts as a starting material.
Man går frem som beskrevet i eksempel 8, men i stedet for NH^ anvendes 33%'s NH^OH. Det affedtede tørmycelium vaskes med vand ved 30PC.Proceed as described in Example 8, but 33% of NH 2 OH is used instead of NH 2. The degreased dry mycelium is washed with water at 30PC.
Eksempel 11Example 11
Som udgangsmateriale anvendes den samme cellemasse som beskrevet i eksempel 10. I stedet for methanol anvendes ethanol. Temperaturen under vandekstraktionen forhøjes til 85°C og holdes her i 15 minutter.As the starting material, the same cell mass is used as described in Example 10. Instead of methanol, ethanol is used. The temperature during the water extraction is raised to 85 ° C and kept here for 15 minutes.
I følgende tabel I a+b er resultaterne af eksemplerne 1-11 anført.The following Table I a + b lists the results of Examples 1-11.
10 14651110 146511
Tabel laTable 1a
Fjernelse af lipiderne 100 g anvendt cellemasse_Removal of the lipids 100 g of cell mass used
Nuclein- NH^ (g) el.Nuclein-NH 2 (g) el.
Fedt syre Opløsningsmiddel NH.OHFatty Acid Solvent NH.OH
Eks. Art_ vægt% vægt%_300 g_(33%'s, ml) 1 Methylomona 7 11,2 Methanol NH3 10 2 " 7 11,2 Methanol NH4OH 30 3 " 7 11,2 Methanol NH^OH 60 4 " 7 11,2 Ethanol NH4OH 30 5 " 7 11,2 Glykolmonome- NH4OH 60 thylether 6 " 7 11,2 i-Propanol NH4OH 30 7 " 9,6 15,4 Methanol NH^ 15 8 Candida lipo- 8,2 7,5 Methanol NH^ 10 lytica 9 " 8,2 7,5 Ethanol ΝΗ^ΟΗ 60 10 Tørmycelium 3,5 2,6 Methanol NH4OH 30 11 " 3,5 2,6 Ethanol NH4OH 30Ex. Species wt% wt% 300 g (33%, ml) 1 Methylomona 7 11.2 Methanol NH3 10 2 "7 11.2 Methanol NH4OH 30 3" 7 11.2 Methanol NH4 OH 60 4 "7 11.2 Ethanol NH4OH 5 "7 11.2 Glycol monomer NH4OH 60 thyl ether 6" 7 11.2 i-Propanol NH4OH 30 7 "9.6 15.4 Methanol NH4 8 Candida lipo 8.2 7.5 Methanol NH4 10 lytica 9 "8.2 7.5 Ethanol ΝΗ ^ ΟΗ 60 10 Dry Mycelium 3.5 2.6 Methanol NH4OH 30 11" 3.5 2.6 Ethanol NH4OH 30
Tabel IbTable Ib
Fjernelse af nucleinsyrerne _Vaskevand_ Opnået cellemasse_ Mængde Temp. Mængde Fedtstoffer NucleinsyreRemoval of the Nucleic Acids _Washing Water_ Obtained Cell Mass_ Quantity Temp. Amount of Fats Nucleic Acid
Eks._liter pH ^_(£)_vægt%_vsgt% 1 0,9 6,9 55 68 0,8 1,5 2 0,9 6,9 60 67 1,3 1,2 3 0,9 7,0 65 63 2,0 1,1 4 0,9 6,9 50 67 2,2 1,5 5 0,9 7,1 55 63 2,8 2,3 6 0,9 7,0 60 64 3,4 4,0 7 0,9 7,2 65 62 1,2 1,4 8 1,0 6,8 50 68 1,4 0,4 9 1,0 6,5 45 67 1,8 0,7 10 0,9 6,5 30 78 1,1 0,5 11 0,9 6,5 85 79 1,3 0,8Ex. Liters pH ^ (£) _% by weight% 1 0.9 6.9 55 68 0.8 1.5 2 0.9 6.9 60 67 1.3 1.2 3 0.9 7.0 65 63 2.0 1.1 4 0.9 6.9 50 67 2.2 1.5 5 0.9 7.1 55 63 2.8 2.3 6 0.9 7.0 60 64 3.4 4.0 7 0.9 7.2 65 62 1.2 1.4 8 1.0 6.8 50 68 1.4 0.4 9 1.0 6.5 45 67 1.8 0.7 10 0 , 9 6.5 30 78 1.1 0.5 11 0.9 6.5 85 79 1.3 0.8
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2633666 | 1976-07-27 | ||
| DE2633666A DE2633666C3 (en) | 1976-07-27 | 1976-07-27 | Reduction of the lipid and nucleic acid content in microbial cell mass |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| DK337677A DK337677A (en) | 1978-01-28 |
| DK146511B true DK146511B (en) | 1983-10-24 |
| DK146511C DK146511C (en) | 1984-04-02 |
Family
ID=5984032
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK337677A DK146511C (en) | 1976-07-27 | 1977-07-26 | PROCEDURE FOR REDUCING LIPID AND NUCLEIC ACID CONTENTS IN MICROBIAL CELL MASS |
Country Status (28)
| Country | Link |
|---|---|
| JP (1) | JPS5315489A (en) |
| AT (1) | AT357502B (en) |
| AU (1) | AU512670B2 (en) |
| BE (1) | BE857229A (en) |
| BG (1) | BG37997A3 (en) |
| CA (1) | CA1101724A (en) |
| CH (1) | CH635615A5 (en) |
| CS (1) | CS207473B2 (en) |
| DD (1) | DD131072A5 (en) |
| DE (1) | DE2633666C3 (en) |
| DK (1) | DK146511C (en) |
| EG (1) | EG12626A (en) |
| ES (1) | ES460877A1 (en) |
| FI (1) | FI57443C (en) |
| FR (1) | FR2359896A1 (en) |
| GB (1) | GB1584194A (en) |
| GR (1) | GR64056B (en) |
| HU (1) | HU176802B (en) |
| IL (1) | IL52594A (en) |
| IT (1) | IT1082226B (en) |
| NL (1) | NL7708171A (en) |
| NO (1) | NO147034C (en) |
| PL (1) | PL107949B1 (en) |
| PT (1) | PT66849B (en) |
| RO (1) | RO71982A (en) |
| SE (1) | SE432609B (en) |
| SU (1) | SU791257A3 (en) |
| ZA (1) | ZA774517B (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2748885A1 (en) * | 1977-11-02 | 1979-05-03 | Hoechst Ag | PROCESS FOR IMPROVING THE PROPERTIES OF SCROTS OR FLOURS FROM OIL SEEDS |
| DE2907065A1 (en) | 1979-02-23 | 1980-09-04 | Hoechst Ag | METHOD FOR GREATING LEATHER AND FUR SKINS |
| CA1120314A (en) * | 1979-08-22 | 1982-03-23 | John A. Ridgway | Treatment of proteinaceous materials with anhydrous ammonia gas |
| DE3143947A1 (en) * | 1981-11-05 | 1983-05-11 | Hoechst Ag, 6230 Frankfurt | "FUNCTIONAL PROTEIN HYDROLYSATE, METHOD FOR THE PRODUCTION THEREOF AND FOOD CONTAINING THIS PROTEIN HYDROLYSATE" |
| DE3228500A1 (en) * | 1982-07-30 | 1984-02-02 | Basf Ag, 6700 Ludwigshafen | METHOD FOR PURIFYING CARBONIC ACID ESTERS CONTAINING ALDEHYDE, ACETALS AND / OR UNSATURATED COMPOUNDS |
| EP0805201B1 (en) * | 1995-05-29 | 2000-01-12 | Otkrytoe Akcionernoe Obschestvo"Nauchno-Issledovatelsky Institut Vychislitelnykh Komplexov im. M.A. Karceva", | Method of obtaining a biomass of microorganisms with a low nucleic acids content |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3615654A (en) * | 1968-05-17 | 1971-10-26 | Cpc International Inc | Method of treating microbial cells |
| IT954172B (en) * | 1970-07-24 | 1973-08-30 | Standard Oil Co | PROCEDURE FOR EXTRACTING PROTEIN MATERIAL FROM UNICELLULAR MICROBIAL ORGANISMS AND PRODUCT OBTAINED |
| SU419551A1 (en) * | 1972-01-18 | 1974-03-15 | В. Ф. Фоменков Институт биологической физики СССР | THERMAL FLOW METER |
| GB1400691A (en) * | 1973-02-08 | 1975-07-23 | British Petroleum Co | Process for the production of proteinaceous material |
| GB1408845A (en) * | 1973-02-13 | 1975-10-08 | Ranks Hovis Mcdougall Ltd | Production of edible protein containing substances |
| JPS5411379B2 (en) * | 1973-02-21 | 1979-05-15 |
-
1976
- 1976-07-27 DE DE2633666A patent/DE2633666C3/en not_active Expired
-
1977
- 1977-07-20 ES ES460877A patent/ES460877A1/en not_active Expired
- 1977-07-22 CH CH913977A patent/CH635615A5/en not_active IP Right Cessation
- 1977-07-22 BG BG036986A patent/BG37997A3/en unknown
- 1977-07-22 NL NL7708171A patent/NL7708171A/en not_active Application Discontinuation
- 1977-07-25 FI FI772272A patent/FI57443C/en not_active IP Right Cessation
- 1977-07-25 RO RO7791163A patent/RO71982A/en unknown
- 1977-07-25 IL IL52594A patent/IL52594A/en unknown
- 1977-07-25 IT IT26084/77A patent/IT1082226B/en active
- 1977-07-25 SE SE7708539A patent/SE432609B/en not_active IP Right Cessation
- 1977-07-25 GR GR54033A patent/GR64056B/en unknown
- 1977-07-25 EG EG439/77A patent/EG12626A/en active
- 1977-07-25 DD DD7700200262A patent/DD131072A5/en unknown
- 1977-07-26 CA CA283,487A patent/CA1101724A/en not_active Expired
- 1977-07-26 SU SU772504953A patent/SU791257A3/en active
- 1977-07-26 PT PT66849A patent/PT66849B/en unknown
- 1977-07-26 HU HU77HO2006A patent/HU176802B/en unknown
- 1977-07-26 AU AU27319/77A patent/AU512670B2/en not_active Expired
- 1977-07-26 NO NO772658A patent/NO147034C/en unknown
- 1977-07-26 DK DK337677A patent/DK146511C/en not_active IP Right Cessation
- 1977-07-26 PL PL1977199855A patent/PL107949B1/en unknown
- 1977-07-26 AT AT544077A patent/AT357502B/en not_active IP Right Cessation
- 1977-07-26 ZA ZA00774517A patent/ZA774517B/en unknown
- 1977-07-27 GB GB31537/77A patent/GB1584194A/en not_active Expired
- 1977-07-27 BE BE179698A patent/BE857229A/en not_active IP Right Cessation
- 1977-07-27 FR FR7723082A patent/FR2359896A1/en active Granted
- 1977-07-27 CS CS764982A patent/CS207473B2/en unknown
- 1977-07-27 JP JP8934977A patent/JPS5315489A/en active Granted
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4206243A (en) | Process for reducing the contents of lipids and nucleic acid in microbial cell masses | |
| DK146511B (en) | PROCEDURE FOR REDUCING LIPID AND NUCLEIC ACID CONTENTS IN MICROBIAL CELL MASS | |
| JP2010011760A (en) | Method for producing high protein low glucosinolate rapeseed meal | |
| US2635069A (en) | Production of catalase from mold | |
| US3163638A (en) | Extraction of ribonucleic acid | |
| US4797365A (en) | Active dried yeast | |
| KR810001964B1 (en) | Process for reducing the contents of lipids and nucleic acid in mocrobial cell masses | |
| US3686144A (en) | Recovery of yeast proteins in refined form and with high yield by dehydration with an alkanol followed by acidic esterification | |
| JP7454595B2 (en) | Non-toxic proteins and omega-3s from algae and methods for producing them | |
| NO811943L (en) | PROCEDURE FOR PREPARING LOW NUCLEIC ACID PROCEDURE | |
| EP0443925B1 (en) | Process for the microbiological obtention of irones | |
| FR2497230A1 (en) | PROCESS FOR THE PREPARATION OF OPTICALLY ACTIVE MONOALKYL ESTERS OF B- (S) -AMINOGLUTARIC ACID | |
| US3733253A (en) | Method of producing citric acid | |
| US1239526A (en) | Stable concentrated preparation for the indigo fermentation-vats. | |
| US3006932A (en) | Production of ergosterol from yeast | |
| NO880590L (en) | HIGHER ALKYLPYRROLIDON EXTRACTING AGENTS FOR WATER SOLUBLE PHENOLIC OR CARBOCYCLIC ANTIBIOTICS. | |
| NO147878B (en) | PROCEDURE FOR THE EXTRACTION OF ZEARALENON. | |
| SU557785A1 (en) | A method of processing microbial biomass | |
| JPS59198992A (en) | Purification of microorganism protein isolate | |
| JP2675047B2 (en) | Method for forming amphotericin B crystals in fermentation medium | |
| JP2024125709A (en) | Method for producing protein-containing Aspergillus oryzae tissue product | |
| Levene et al. | THE RELATION OF CHEMICAL STRUCTURE TO THE RATE OF HYDROLYSIS OF PEPTIDES. | |
| NO750432L (en) | ||
| JPS6012993A (en) | Method for producing optically active carboxylic acid | |
| JPS6148914B2 (en) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PBP | Patent lapsed |